Julie Hoxie Bowers
Primary Care · Graceville, FLNPI 1134775745
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.1% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by AbbVie at 24.4% of the total. Among primary care clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 217 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$876
- AstraZeneca$331
- Lilly USA, LLC$287
- Pfizer$275
- GSK$272
- Novo Nordisk$268
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,52398%
- Education$682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$3,591 in reported general payments places this provider in the 90th percentile of 725 primary care providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 90 | $68,042 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 66 | $53,739 |
| OzempicSemaglutide | 39 | $48,839 |
| TrulicityDulaglutide | 31 | $42,958 |
| MounjaroTirzepatide | 19 | $35,037 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 44 | $29,202 |
| VraylarCariprazine Hcl | 18 | $25,987 |
| UbrelvyUbrogepant | 18 | $22,181 |
| Nurtec OdtRimegepant Sulfate | 14 | $17,921 |
| EliquisApixaban | 27 | $13,267 |
| JardianceEmpagliflozin | 13 | $7,532 |
| SymbicortBudesonide/Formoterol Fumarate | 14 | $4,375 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 150 | $3,737 |
| Fluticasone Propionate | 168 | $2,967 |
| Omeprazole | 182 | $2,707 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $331 | $101,619148 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $287 | $77,99550 claims |
| GSKTrelegy Ellipta | $272 | $53,73966 claims |
| Novo NordiskOzempic | $268 | $48,83939 claims |
| AbbVieVraylar, Ubrelvy | $876 | $48,16936 claims |
| PfizerNurtec Odt, Eliquis | $275 | $31,18841 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 725 primary care providers in Florida.
Other primary care in Graceville
- Paul ChanOrlando$447K
- Jenny WestPensacola$80K
- Railet RodriguezAltamonte Springs$14K
- Kevin HanawayFort Lauderdale$12K
- Kelly ChewningAlachua$11K
- Yolanda PalmeroSaint Cloud$11K
- Erica ClarkCitrus Springs$11K
- Michelle SelvaggiLakewood Ranch$10K
- Kristen DeasonTallahassee$10K
- Robert PerriPalm Coast$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.